Rating History for GlaxoSmithKline (GSK) by BNP Paribas Exane
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/15/2025 | N/A | New Coverage | Neutral (N/A) |
35.25 (N/A) |
35.28 (52.38) |
48.47% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/15/2025 | N/A | New Coverage | Neutral (N/A) |
35.25 (N/A) |
35.28 (52.38) |
48.47% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||